Glucocorticoid receptor antagonist Org34517 as a chemosensitizing agent for ovarian cancer

Authors :: Neil D. Theise
Anthony R. Arment
Matthew Witman
Paul Gonzales
Stephen T. Gately
Maggie Valenzuela
Source :: Journal of Clinical Oncology. 33:e16556-e16556
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: e16556 Background: Anti-tumor activity has been predicted for glucocorticoid receptor antagonists (GRAs) for some solid organ malignanies. Org34517, the first selective GRA studied in humans, has s...

Subjects :: Cancer Research
business.industry
Antiglucocorticoid
Glucocorticoid Receptor Antagonists
Pharmacology
medicine.disease
chemistry.chemical_compound
Oncology
chemistry
parasitic diseases
medicine
Chemosensitizing agent
Ovarian cancer
business

Full Text Access

Tools